Maya BJA

Language: Spanish
References: 14
Page: 31-40
PDF size: 135.07 Kb.

ABSTRACT

The pediatric population, although to a lesser extent it has also been affected by COVID-19, below are six main points for doctors who are on the front line of battle with this population. The first point focuses on the care of the child in the doctor’s office and the evaluation of the pediatrician, the second of them the most frequent clinical presentations of the disease in this population, the third, on the characteristics present in seriously ill patients and critical with COVID-19, the fourth, of the multisystemic inflammatory syndrome associated with the SARS-CoV-2 virus, the fifth point is the seasonal considerations together with the coexistence between the SARS-CoV-2 virus and influenza and finally the presentation of cases clinics of patients infected with the virus. It is important to pay attention to the focus points to provide adequate management to the pediatric patient at the first level of care.

REFERENCES

1. Control y seguimiento de la nutrición, el crecimiento y desarrollo de la niña y del niño menor de 5 años. México: Secretaría de Salud; 2 de diciembre de 2015.

2. Comunicado oficial. Dirección General de Epidemiología. Secretaría de Salud. Agosto 24, 2020.

3. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/.

4. Davies CJ, Waters D. A systematic review of the psychometric properties of bronchiolitis assessment tools. J Adv Nurs. 2017; 73 (3): 286-301. doi: https://doi.org/10.1111/jan.13098.

5. De Souza TH, Nadal JA, Nogueira RJ, Pereira RM, Brandao MB. Clinical manifestations of children with COVID-19: a systematic review. Pediatric Pulmonology. 2020; 1-8. doi: 10.1002/ppul.24885.

6. Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci FI. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020; 9 (4): 641-708. Available in: https://doi.org/10.1016/S2352-4642(20)30177-2.

7. Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020; 20 (11): E276-E288. https://doi.org/10.1016/S1473-3099(20)30651-4.

8. Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley SJ et al. COVID-19 and Kawasaki disease: novel virus and novel case. hospital pediatrics. 2020; 10 (6): 537. doi: https://doi.org/10.1542/hpeds.2020-0123.

9. Liguoro I, Pilotto C, Bonanni M, Ferrari M, Pusiol A, Nocerino A et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020; 1-18. doi: https://doi.org/10.1007/s00431-020-03684-7.

10. Ludvigsson J. Children are unlikely to be the main drivers of the COVID-19 pandemic-A systematic review. Acta Paediatrica. 2020; 109: 1525-1530. doi: 10.1111/apa.15371.

11. Abrams JY, Godfred-Cato SE, Oster ME, Chow EJ, Koumans EH, Bryant B et al. Multisystem inflammatory syndrome in children (MIS-C) Associated with SARS-CoV-2: a systematic review. J Pediatr. 2020; 226: 45-54. doi: https://doi.org/10.1016/j.jpeds.2020.08.003.

12. Mustafa NM, Selim LA. Characterisation of COVID-19 pandemic in paediatric age group: a systematic review and meta-analysis. J Clin Virol. 2020; 128: 1-9. doi: 10.1016/j.jcv.2020.104395.

13. Chang T, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-19: a systematic review and meta-analysis. J Formos Med Assoc. 2020; 119: 982-989. doi: https://doi.org/10.1016/j.jfma.2020.04.007.

14. Yasuhara J, Kuno T, Takagi H, Sumitomo N. Clinical characteristics of COVID-19 in children: a systematic review. Pediatric Pulmonology. 2020; 1-11. doi: 10.1002/ppul.24991.